Sugi Predict

Sugi Predict / Compounds / SCHEMBL711273

SCHEMBL711273

SCHEMBL711273

CC(C)Oc1cc(OCc2ccccc2)ccc1-c1nc2cc(-c3cccc(F)c3)cnc2[nH]1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GPR34 Q9UPC5 2/20 0.40
▸ PDGFRB P09619 2/20 0.38
▸ PDGFRA P16234 2/20 0.38
▸ PDE4B Q07343 2/20 0.38
▸ GRIN1 Q05586 1/20 0.38
▸ GRIN2B Q13224 1/20 0.38
▸ MAPT P10636 2/20 0.37
▸ NPSR1 Q6W5P4 2/20 0.37
▸ KDM4E B2RXH2 1/20 0.37
▸ HSP90AA1 P07900 1/20 0.37
▸ MAPK1 P28482 1/20 0.37
▸ TDP1 Q9NUW8 1/20 0.37
▸ WNT1 P04628 1/20 0.37
▸ PDE10A Q9Y233 1/20 0.37
▸ MAOB P27338 2/20 0.36
▸ C5AR1 P21730 1/20 0.36
▸ FFAR1 O14842 1/20 0.36
▸ NLRP3 Q96P20 1/20 0.36
▸ MPO P05164 1/20 0.36
▸ MCL1 Q07820 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL708886 0.93 GPR34 (0.40) GPR34PDGFRBPDGFRAPDE4BWNT1
SCHEMBL10206529 0.93 MAPT (0.41) PDGFRBPDGFRAPDE4BMAPTNPSR1
SCHEMBL712059 0.92 MCL1 (0.40) GPR34PDGFRBPDGFRAMAPTNPSR1
SCHEMBL711250 0.90 GPR34 (0.41) GPR34GRIN1GRIN2B
SCHEMBL709187 0.90 MAPT (0.36) PDGFRBPDGFRAPDE4BGRIN1GRIN2B
SCHEMBL710291 0.88 FFAR1 (0.37) PDGFRBPDGFRAMAPTNPSR1KDM4E
SCHEMBL720489 0.88 MAPT (0.46) PDGFRBPDGFRAMAPTNPSR1KDM4E
Trifluoroacetic Acid SCHEMBL710810 0.87 MCL1 (0.41) GPR34MAPTNPSR1KDM4EHSP90AA1
SCHEMBL713547 0.87 PRMT5 (0.39) PDGFRBPDGFRAMAPTNPSR1KDM4E
SCHEMBL712826 0.87 MAP4K4 (0.43) GPR34MAPTNPSR1MAPK1MCL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1940837-B1 IMIDAZOPYRIDINE COMPOUNDS TAKEDA PHARMACEUTICAL (JP) 2012-11-07 — — EP disclosed
US-8124617-B2 Imidazopyridine compounds TAKEDA SAN DIEGO, INC. (US) 2012-02-28 — — US disclosed
US-8124617-B2 Imidazopyridine compounds TAKEDA SAN DIEGO, INC. (US) 2012-02-28 — — US disclosed
US-8124617-B2 Imidazopyridine compounds TAKEDA SAN DIEGO, INC. (US) 2012-02-28 — — US disclosed
US-20100069431-A1 IMIDAZOPYRIDINE COMPOUNDS TAKEDA SAN DIEGO, INC. 2010-03-18 — — US disclosed
US-20100069431-A1 IMIDAZOPYRIDINE COMPOUNDS TAKEDA SAN DIEGO, INC. 2010-03-18 — — US disclosed
US-20100069431-A1 IMIDAZOPYRIDINE COMPOUNDS TAKEDA SAN DIEGO, INC. 2010-03-18 — — US disclosed
EP-1940837-A2 IMIDAZOPYRIDINE COMPOUNDS Takeda Pharmaceutical Company Limited (JP) 2008-07-09 — — EP disclosed
WO-2007028135-A2 IMIDAZOPYRIDINE COMPOUNDS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2007-03-08 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100069431-A1 IMIDAZOPYRIDINE COMPOUNDS GCK, GCKR, KHK GPR34 2350/4885PDGFRB 3099/4885PDGFRA 3259/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.